Aldevron, a biotech company located out of Fargo North Dakota, has decided to produce cancer vaccines created by a CureLab Oncology, based out of Canton MA. CureLab Oncology as a result with be moving most of its operations to Fargo or Grand Forks North Dakota. CureLab CEO Alex Schneider said that the company will be relocating some people but plans to hire much of the staff from local graduates.
The DNA based vaccines developed by CureLab Oncology have so far been tested on animal studies and shown hope in the prospect of suppessing cancers of the lung and breast. the effects when tested showed to inhibit growth in the main tumors, but also slowed down and inhibited metastases. The vaccine has also shown to create memory in the immune system, which allows it to also fight off the affects.
Other Related Articles